TNF-α gene expression is increased following zinc supplementation in type 2 diabetes mellitus

Genes and Nutrition

Volumn 10, Issue 1, 2015, Pages

  Chu, Anna ^a   Foster, Meika ^a   Hancock, Dale ^a   Bell Anderson, Kim ^a   Petocz, Peter ^b   Samman, Samir ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cytokines; Gene expression; Inflammation; Metallothionein; Type 2 diabetes mellitus; Zinc transporters

Indexed keywords

EID: 84938065111     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-014-0440-4     Document Type: Article

References (43)

1. Aydemir TB, Blanchard RK, Cousins RJ (2006) Zinc supplementation of young men alters metallothionein, zinc transporter, and cytokine gene expression in leukocyte populations. Proc Natl Acad Sci USA 103:1699–1704. doi:10.1073/pnas.0510407103
2. Babula P, Masarik M, Adam V et al (2012) Mammalian metallothioneins: properties and functions. Metallomics 4:739–750. doi:10.1039/c2mt20081c
3. Banerjee M, Saxena M (2012) Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes. Clin Chim Acta 413:1163–1170. doi:10.1016/j.cca.2012.03.021
4. Bao B, Prasad A (2010) Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr 91:1634–1641. doi:10.3945/ajcn.2009.28836.1634
5. Calder PC (2006) N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83:1505S–1519S
6. Capdor J, Foster M, Petocz P, Samman S (2013) Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans. J Trace Elem Med Biol 27:137–142. doi:10.1016/j.jtemb.2012.08.001
7. Chang K-L, Hung T-C, Hsieh B-S et al (2006) Zinc at pharmacologic concentrations affects cytokine expression and induces apoptosis of human peripheral blood mononuclear cells. Nutrition 22:465–474. doi:10.1016/j.nut.2005.11.009
8. Cnop M, Welsh N, Jonas J et al (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes. Diabetes 54:97–107
9. Cohen L, Sekler I, Hershfinkel M (2014) The zinc sensing receptor, ZnR/GPR39, controls proliferation and differentiation of colonocytes and thereby tight junction formation in the colon. Cell Death Dis 5:e1307. doi:10.1038/cddis.2014.262
10. De Mello VDF, Kolehmanien M, Schwab U et al (2012) Gene expression of peripheral blood mononuclear cells as a tool in dietary intervention studies: what do we know so far? Mol Nutr Food Res 56:1160–1172. doi:10.1002/mnfr.201100685
11. Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107. doi:10.1038/nri2925
12. Egefjord L, Jensen JL, Bang-Berthelsen CH et al (2009) Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis? BMC Endocr Disord 9:7. doi:10.1186/1472-6823-9-7
13. Foster M, Samman S (2010) Zinc and redox signaling: perturbations associated with cardiovascular disease and diabetes mellitus. Antioxid Redox Signal 13:1549–1573. doi:10.1089/ars.2010.3111
14. Foster M, Samman S (2012) Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease. Nutrients 4:676–694. doi:10.3390/nu4070676
15. Foster M, Petocz P, Samman S (2010) Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: a meta-analysis of randomised controlled trials. Atherosclerosis 210:344–352. doi:10.1016/j.atherosclerosis.2009.11.038
16. Foster M, Hancock D, Petcoz P, Samman S (2011) Zinc transporter genes are coordinately expressed in men and women independently of dietary or plasma zinc. J Nutr 1195–1201. doi:10.3945/jn.111.140053
17. Foster M, Petocz P, Caterson ID, Samman S (2013a) Effects of zinc and α-linolenic acid supplementation on glycemia and lipidemia in women with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. J Diabetes Res Clin Metab. doi:10.7243/2050-0866-2-3
18. Foster M, Petocz P, Samman S (2013b) Inflammation markers predict zinc transporter gene expression in women with type 2 diabetes mellitus. J Nutr Biochem 24:1655–1661. doi:10.1016/j.jnutbio.2013.02.006
19. Foster M, Chu A, Petocz P, Samman S (2014) Zinc transporter gene expression and glycemic control in post-menopausal women with type 2 diabetes mellitus. J Trace Elem Med Biol. doi:10.1016/j.jtemb.2014.07.012 [Epub ahead of print]
20. Haase H, Maret W (2005) Fluctuations of cellular, available zinc modulate insulin signaling via inhibition of protein tyrosine phosphatases. J Trace Elem Med Biol 19:37–42. doi:10.1016/j.jtemb.2005.02.004
21. Hennigar SR, Kelleher SL (2012) Zinc networks: the cell-specific compartmentalization of zinc for specialized functions. Biol Chem 393:565–578. doi:10.1515/hsz-2012-0128
22. Hojyo S, Miyai T, Fujishiro H et al (2014) Zinc transporter SLC39A10/ZIP10 controls humoral immunity by modulating B-cell receptor signal strength. Proc Natl Acad Sci USA 111:11786–11791. doi:10.1073/pnas.1323557111
23. Huang L (2014) Zinc and its transporters, pancreatic β-cells, and insulin metabolism. Vitam Horm 95:365–390. doi:10.1016/B978-0-12-800174-5.00014-4
24. Huang L, Tepaamorndech S (2013) The SLC30 family of zinc transporters—a review of current understanding of their biological and pathophysiological roles. Mol Aspects Med 34:548–560. doi:10.1016/j.mam.2012.05.008
25. Huber AM, Gershoff SN (1973) Effect of zinc deficiency in rats on insulin release from the pancreas. J Nutr 103:1739–1744
26. Jansen J, Karges W, Rink L (2009) Zinc and diabetes—clinical links and molecular mechanisms. J Nutr Biochem 20:399–417. doi:10.1016/j.jnutbio.2009.01.009
27. Jeong J, Eide DJ (2013) The SLC39 family of zinc transporters. Mol Aspects Med 34:612–619. doi:10.1016/j.mam.2012.05.011
28. Kelleher S, McCormick NH, Velasquez V, Lopez V (2011) Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland. Adv Nutr 2:101–111. doi:10.3945/an.110.000232
29. Kim AM, Tingen CM, Woodruff TK (2010) Sex bias in trials and treatment must end. Nature 465:688–689. doi:10.1038/465688a
30. Lichten LA, Cousins RJ (2009) Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr 29:153–176. doi:10.1146/annurev-nutr-033009-083312
31. Liuzzi JP, Lichten LA, Rivera S et al (2005) Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci USA 102:6843–6848. doi:10.1073/pnas.0502257102
32. Miyai T, Hojyo S, Ikawa T et al (2014) Zinc transporter SLC39A10/ZIP10 facilitates antiapoptotic signaling during early B-cell development. Proc Natl Acad Sci U S A. doi:10.1073/pnas.1323549111
33. Mlinar B, Marc J, Janez A, Pfeifer M (2007) Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 375:20–35. doi:10.1016/j.cca.2006.07.005
34. Noh H, Paik HY, Kim J, Chung J (2014) The alteration of zinc transporter gene expression is associated with inflammatory markers in obese women. Biol Trace Elem Res 158:1–8. doi:10.1007/s12011-014-9902-1
35. Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813–823. doi:10.2337/diacare.27.3.813
36. Powell EE, Kroon PA (1994) Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver. J Clin Invest 93:2168–2174. doi:10.1172/JCI117213
37. Prasad A, Beck F (2007) Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 85:837–844
38. Prasad AS, Bao B, Beck FWJ, Sarkar FH (2006) Correction of interleukin-2 gene expression by in vitro zinc addition to mononuclear cells from zinc-deficient human subjects: a specific test for zinc deficiency in humans. Transl Res 148:325–333. doi:10.1016/j.trsl.2006.07.008
39. Rudkowska I, Raymond C, Ponton A et al (2011) Validation of the use of peripheral blood mononuclear cells as surrogate model for skeletal muscle tissue in nutrigenomic studies. OMICS 15:1–7. doi:10.1089/omi.2010.0073
40. Scuderi P (1990) Differential effects of copper and zinc on human peripheral blood monocyte cytokine secretion. Cell Immunol 126:391–405. doi:10.1016/0008-8749(90)90330-T
41. Wellinghausen N, Driessen C, Rink L (1996) Stimulation of human peripheral blood mononuclear cells by zinc and related cations. Cytokine 8:767–771. doi:10.1006/cyto.1996.0102
42. Zhao G, Etherton T, Martin K (2004) Dietary α-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 134:2991–2997
43. Zhao G, Etherton TD, Martin KR et al (2007) Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr 85:385–391